F. Moraes

Glycosaminoglycan backbone is not required for the modulation of hemostasis: effect of different heparin derivatives and non-glycosaminoglycan analogs.

H. Nader, J. Fareed, R. P. Cavalheiro, 2012, Matrix biology : journal of the International Society for Matrix Biology.

Structural features and bleeding activity of commercial low molecular weight heparins: neutralization by ATP and protamine.

S. Shinjo, H. Nader, C. Dietrich, 1999, Seminars in thrombosis and hemostasis.

Structural and Hemostatic Activities of a Sulfated Galactofucan from the Brown Alga Spatoglossum schroederi

S. S. Veiga, A. Valente, R. Torquato, 2005, Journal of Biological Chemistry.